.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Unpacking Key Data from ASH 2024

Andre Goy, MD; Jamie Koprivnikar, MD, and Harsh Parmar, MD, discuss how recent advancements in CAR T-cell therapies, bispecific antibodies, and targeted treatments are transforming the management of hematologic malignancies, with particular focus on real-world comparative analyses of different approaches in multiple myeloma, lymphoma, and leukemia.